Cantitate/Preț
Produs

Club Drugs and Novel Psychoactive Substances: The Clinician's Handbook

Autor Owen Bowden-Jones, Dima Abdulrahim
en Limba Engleză Paperback – 7 oct 2020
Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect - sedative, stimulant and hallucinogenic - the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.
Citește tot Restrânge

Preț: 22130 lei

Preț vechi: 23294 lei
-5% Nou

Puncte Express: 332

Preț estimativ în valută:
4235 4455$ 3506£

Carte tipărită la comandă

Livrare economică 14-28 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781911623090
ISBN-10: 1911623095
Pagini: 150
Dimensiuni: 122 x 186 x 7 mm
Greutate: 0.14 kg
Editura: Cambridge University Press
Colecția RCPsych Publications
Locul publicării:Cambridge, United Kingdom

Cuprins

Part I: 1. Introduction 2. What are NPS and Club Drugs and why are they important; 3. A brief history of NPS production and distribution; 4. Drugs classification framework for Club Drugs and NPS; 5. Clinical challenge of Club Drugs and NPS; Part II. Stimulant Drugs; 6. Stimulant drugs: introduction; 7. Stimulant drugs: cocaine; 8. Stimulant drugs: amphetamine-type; 9. Stimulant drugs: methamphetamine; 10. Stimulant drugs: MDMA; 11. Stimulant drugs: synthetic cathinones; Part III. Depressant Drugs; 12. Depressant drugs: introduction; 13. Depressant drugs: GHB/GBL; 14. Depressant drugs: Fentanyl, Fentanyl analogues and other opioid NPS; 15. Depressant drugs: Benzodiazepine NPS; 16. Depressant drugs: Ketamine and its anaologues; Part IV. Synthetic Cannabinoid Receptor Agonsits; 17. Synthetic cannabinoid receptor agonists (SCRAs); Part V. Hallucinogens; 18. Hallucinogens; Part VI. Concluding Remarks and References; 19. Concluding Remarks; 20. References.


Recenzii

'A very nice reading; very easy to follow and with a clear focus on the clinical issues, e.g. what the practicing clinician … need to know to interact with the client; to make a diagnosis; and identify a proper treatment and management approach. Although the language and the tones here used are straightforward and direct, the content of the document is precise, really updated, and definitely non-judgmental. I particularly enjoyed reading the clinical vignettes; they illustrate a range of complex issues in a way which is simple enough for even the non experienced clinician/non experienced trainee to be able to understand. There are a few sections, e.g. the one on psychedelic phenethylamines and GHB, which are of particular value. The focus on GHB withdrawal is important and detailed.' Fabrizio Schifano, Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, University of Hertfordshire

Descriere

Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect - sedative, stimulant and hallucinogenic - the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.


Notă biografică